Search Results - Niels Halama
- Showing 1 - 20 results of 41
- Go to Next Page
-
1
-
2
Genomics and emerging biomarkers for immunotherapy of colorectal cancer by Jakob Nikolas Kather, Niels Halama, Dirk Jaeger
Published 2018Revisão -
3
100,000 Histological Images Of Human Colorectal Cancer And Healthy Tissue by Jakob Nikolas Kather, Niels Halama, Alexander Marx
Published 2018Conjunto de Dados -
4
-
5
-
6
Detailed resolution analysis reveals spatial T cell heterogeneity in the invasive margin of colorectal cancer liver metastases associated with improved survival by Anna Berthel, Inka Zoernig, Nektarios A. Valous, Christoph Kahlert, Fee Klupp, Alexis Ulrich, Juergen Weitz, Dirk Jaeger, Niels Halama
Published 2017Artigo -
7
Blood markers of oxidative stress are strongly associated with poorer prognosis in colorectal cancer patients by Daniel Boakye, Lina Jansen, Ben Schöttker, Eugène Jansen, Martin Schneider, Niels Halama, Xīn Gào, Jenny Chang‐Claude, Michael Hoffmeister, Hermann Brenner
Published 2020Artigo -
8
Soluble immune checkpoints and T-cell subsets in blood as biomarkers for resistance to immunotherapy in melanoma patients by Devayani Machiraju, Melanie Wiecken, Nina Lang, Ingrid Hülsmeyer, Jasmin Roth, Timo E. Schank, R Eurich, Niels Halama, Alexander Enk, Jessica C. Hassel
Published 2021Artigo -
9
Granulocyte-Macrophage Colony-Stimulating Factor-Armed Oncolytic Measles Virus Is an Effective Therapeutic Cancer Vaccine by Christian Grossardt, Christine E. Engeland, Sascha Bossow, Niels Halama, Karim Zaoui, Mathias F. Leber, Christoph Springfeld, Dirk Jaeger, Christof von Kalle, Guy Ungerechts
Published 2013Artigo -
10
Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients by Fee Klupp, Lena Neumann, Christoph Kahlert, Johannes Diers, Niels Halama, Clemens M. Franz, Thomas Schmidt, Moritz Koch, Juergen Weitz, Martin Schneider, Alexis Ulrich
Published 2016Artigo -
11
Hepatic metastases of colorectal cancer are rather homogeneous but differ from primary lesions in terms of immune cell infiltration by Niels Halama, Anna Spille, Tina Lerchl, Karsten Brand, Esther Herpel, Stefan Welte, Sophia Keim, Bernd Lahrmann, Fee Klupp, Christoph Kahlert, Jürgen Weitz, Niels Grabe, Dirk Jaeger, Inka Zoernig
Published 2013Artigo -
12
The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications by Klaus Podar, Alexander Zimmerhackl, Mariateresa Fulciniti, Giovanni Tonon, Ursula Hainz, Yu‐Tzu Tai, Sonia Vallet, Niels Halama, Dirk Jäger, Dian L. Olson, Martin Sattler, Dharminder Chauhan, Kenneth C. Anderson
Published 2011Artigo -
13
Natural Killer Cells are Scarce in Colorectal Carcinoma Tissue Despite High Levels of Chemokines and Cytokines by Niels Halama, Monika Braun, Christoph Kahlert, Anna Spille, Christian Quack, Nuh N. Rahbari, Moritz Koch, Jürgen Weitz, Matthias Kloor, Inka Zoernig, Peter Schirmacher, Karsten Brand, Niels Grabe, Christine S. Falk
Published 2011Artigo -
14
Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours by Devalingam Mahalingam, Manish R. Patel, Jasgit C. Sachdev, Lowell L. Hart, Niels Halama, Ramesh K. Ramanathan, John Sarantopoulos, Dirk Völkel, Ashraf Youssef, Floris A. de Jong, Apostolia M. Tsimberidou
Published 2020Artigo -
15
Tadalafil has biologic activity in human melanoma. Results of a pilot trial with <u>Ta</u>dalafil in patients with metastatic Melanoma (TaMe) by Jessica C. Hassel, Huanhuan Jiang, Carolin Bender, Julia K. Winkler, Alexandra Sevko, Ivan Shevchenko, Niels Halama, Antonia Dimitrakopoulou‐Strauss, Walter E. Haefeli, Dirk Jäger, Alexander Enk, Jochen Utikal, Viktor Umansky
Published 2017Artigo -
16
Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects by Meggy Suarez‐Carmona, Anja Williams, Jutta Schreiber, Nicolas Hohmann, Ulrike Pruefer, Jürgen Krauß, Dirk Jäger, Anna Frömming, Diana Beyer, Dirk Eulberg, Jarf Ulf Jungelius, Matthias Baumann, Aram Mangasarian, Niels Halama
Published 2021Artigo -
17
Seromic profiling of ovarian and pancreatic cancer by Sacha Gnjatic, Erika Ritter, Markus W. Büchler, Nathalia A. Giese, Benedikt Brors, Claudia Frei, Anne Murray, Niels Halama, Inka Zörnig, Yao‐Tseng Chen, Chris Andrews, Gerd Ritter, Lloyd J. Old, Kunle Odunsi, Dirk Jäger
Published 2010Artigo -
18
Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue by Anna Sherwood, Ryan Emerson, Dominique Scherer, James E. Haber, Katharina Buck, Jürgen Staffa, Cindy Desmarais, Niels Halama, Dirk Jaeger, Peter Schirmacher, Esther Herpel, Matthias Kloor, Alexis Ulrich, Martin Schneider, Cornelia M. Ulrich, Harlan Robins
Published 2013Artigo -
19
Prognostic impact of a compartment-specific angiogenic marker profile in patients with pancreatic cancer by Christoph Kahlert, Maria Fiala, Gabriel Musso, Niels Halama, Sophia Keim, Massimiliano Mazzone, Felix Lasitschka, Mathieu Pecqueux, Fee Klupp, Thomas Schmidt, Nuh N. Rahbari, Sebastian Schölch, Christian Pilarsky, Alexis Ulrich, Martin Schneider, Juergen Weitz, Moritz Koch
Published 2014Artigo -
20
Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosis by Christoph Reißfelder, Slava Stamova, Christina Gossmann, Marion Braun, Andreas Bonertz, Ute Walliczek, Mario Grimm, Nuh N. Rahbari, Moritz Koch, Maral Saadati, Axel Benner, Markus W. Büchler, Dirk Jäger, Niels Halama, Khashayarsha Khazaie, Jürgen Weitz, Philipp Beckhove
Published 2014Artigo
Search Tools:
Related Subjects
Medicine
Cancer
Internal medicine
Immunology
Immune system
Biology
Cancer research
Colorectal cancer
Oncology
Immunotherapy
Pathology
Biochemistry
Genetics
Gene
T cell
CD8
Cytokine
Cytotoxic T cell
In vitro
Pancreatic cancer
Tumor microenvironment
Antigen
Cancer cell
Metastasis
Paleontology
Tumor-infiltrating lymphocytes
Adverse effect
Biomarker
Breast cancer
Cancer immunotherapy